Advances in screening instruments for Alzheimer's disease

• Published in: Aging medicine Vol. 2; no. 2; pp. 88 - 93
• Main Authors: Zhou, Xianbo, Ashford, J. Wesson
• Format: Journal Article
• Language: English
• Published: Australia John Wiley & Sons, Inc 01.06.2019; John Wiley and Sons Inc; Wiley
• Subjects: Alzheimer's disease; Biomarkers; Cognition & reasoning; Cognitive ability; Dementia; Disease prevention; Hypertension; Medical imaging; Memory; Neurodegeneration; Review; screen; screening instrument; Special Issue: Dementia; Task forces; United States > US; China; screen; screening instrument; Alzheimer's disease
• ISSN: 2475-0360; 2475-0360
• DOI: 10.1002/agm2.12069

At its fundamental basis, Alzheimer's disease (AD) is a pathological process that affects neuroplasticity, leading to a specific disruption of episodic memory. This review will provide a rationale for calls to screen for the early detection of AD, appraise the currently available cognitive instruments for AD detection, and focus on the development of the MemTrax test, which provides a new approach to detect the early manifestations and progression of the dementia associated with AD. MemTrax assesses metrics that reflect the effects of neuroplastic processes on learning, memory, and cognition, which are affected by age and AD, particularly episodic memory functions, which cannot presently be measured with enough precision for meaningful use. Further development of MemTrax would be of great value to the early detection of AD and would provide support for the testing of early interventions.